Melbourne biotech venture CNSDose secures $1m from two angel investors

Melbourne biotech venture CNSDose secures $1m from two angel investors

Visual of CNSDose homepage. July 2016.

Melbourne biotech startup venture CNSDose has closed a seed investment of nearly $1 million from two angel investors. CNSDose seeks to refine how antidepressants are prescribed to individual patients through the use of a genomic test.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter